A longstanding collaboration
Selectchemie AG is proud to highlight its long-standing collaboration with Novo Nordisk Pharmatech A/S, a leading global producer of high-purity pharmaceutical ingredients.
For many years, this trusted partnership has enabled Selectchemie to distribute pharmaceutical-grade Benzalkonium Chloride to key markets across eastern Europe supporting manufacturers in the production of safe and effective medicines.
“Selectchemie has demonstrated unwavering dedication and competence, not only in distributing our high-quality Benzalkonium Chloride but also in supporting our shared mission of delivering safe and effective medicines to the market, enabling better lives for patients. As we look to the future, we are excited about the many opportunities for growth that lie ahead, and we are committed to strengthening this valuable partnership even further”, Anders Moeller Koefoed, Global Head of Commercial Excellence at Novo Nordisk Pharmatech A/S.
As a valued and accredited partner in selected regions, Selectchemie provides access to Novo Nordisk Pharmatech’s Benzalkonium Chloride, an excipient and active ingredient widely used for its antimicrobial and preservative properties in ophthalmic, nasal, and topical formulations. Manufactured in accordance with ICH Q7 and cGMP standards, the product is known for its consistent quality, full traceability, and regulatory compliance—attributes critical to today’s pharmaceutical landscape.
The following blogs are aimed at providing insights into the applications, regulatory background, and technical benefits of Benzalkonium Chloride. The series will also spotlight the manufacturing excellence of Novo Nordisk Pharmatech and how the partnership helps ensure a dependable supply of this essential API and Excipient.
Stay tuned as we share insights and resources to help our customers better understand the role of Benzalkonium Chloride in pharmaceutical development and manufacturing.
